BUSINESS● LOWSep 28 · Sep 28, 2026, 3:24 PM
Kodiak Sciences skyrockets as Zenkuda, tabirafusp excel in late-stage wet AMD trial
Seeking Alpha Tech · north america
Kodiak Sciences' stock has surged following excellent results from Zenkuda and tabirafusp in their late-stage wet AMD trial. This positive outcome indicates a significant development for the company and its experimental treatments.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS16m agoStable Decoupling : Three Tests For Europe In Face Of Chinese Economic Coercion - Analysiseurasiareview.com · United StatesBUSINESS16m agoNiagara Falls road program beats targets in year 2niagarafallsreview.ca · Canada